-
Mashup Score: 0
Keeping Pace with Rapid Advancements in Multiple Myeloma Care.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HOME - Oncology Roundtable: Treating MF and PV in 2023 - 1 year(s) ago
Oncology Roundtable: Treating MF and PV in 2023.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Access highlights from #ASH2022 on new therapies in MF and PV tomorrow night featuring Jeanne M. Palmer, MD; Bart L. Scott, MD; & Douglas A. Tremblay, MD! Register now: https://t.co/VcfuOP7nCQ #gotoPER #hematology https://t.co/OfqIGNjupS
-
-
Mashup Score: 1
Keeping Pace with Rapid Advancements in Multiple Myeloma Care.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
If you’re a busy clinician wanting to stay informed on emerging trends on multiple mylenoma, join us in DC for our live panel disscusion! Translate recent evidence and guideline-based recommendations into plans for patients. Register now: https://t.co/pKdMEaWKDO #ASH2022 https://t.co/W47wElvhG1
-
-
Mashup Score: 0HOME - Oncology Roundtable: Treating MF and PV in 2023 - 1 year(s) ago
Oncology Roundtable: Treating MF and PV in 2023.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Join #hematology experts for an Oncology Roundtable including case discussions presented by factuly and how to incorporate new therapies in MF and PV using data from #ASH2022. Register now: https://t.co/JgxdzmjoGD #gotoPER https://t.co/O8NZd4mYOs
-
-
Mashup Score: 0HOME - Oncology Roundtable: Treating MF and PV in 2023 - 1 year(s) ago
Oncology Roundtable: Treating MF and PV in 2023.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Bring your most burning questions in the management of MPNs to #hematology experts during our highlights from #ASH2022 symposium. Register now: https://t.co/Yo3zaefv8P #gotoPER https://t.co/lHbV7azsaR
-
-
Mashup Score: 0
Keeping Pace with Rapid Advancements in Multiple Myeloma Care.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Hear from renowned experts in the treatment of multiple myeloma at our panel discussion in Washington DC! Get access to noteworthy data presented at the ASH Annual Meeting. Learn more here: https://t.co/ziKwOO43dH #gotoPER #ASH2022 https://t.co/iluxBELXE5
-
-
Mashup Score: 0
Dr. Adam Lamble of Seattle Children’s Hospital discusses findings that show pathogenic TP53 mutations are associated with a poor prognosis in children with acute myeloid leukemia (AML).
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr Adam Lamble at Seattle Children’s Hospital discusses a new study showing that pathogenic TP53 mutations, while rare, are associated with a poor prognosis in pediatric acute myeloid leukemia (AML). @seattlechildren @AML_Leukemia @AML_Hub #ASH2022 https://t.co/mJRkYJWm4Y
-
-
Mashup Score: 1
Social media is an additional tool that can be used to access myeloma information.
Source: healthtree.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @HealthTreeMM: ASH 2022: Using Social Media for Good #mmsm #healthtreeMM #myeloma #bloodcancer #ASH2022 https://t.co/PuVBn5Xevu https:/…
-
-
Mashup Score: 0
2022 ASH Annual Meeting and Exposition Jorge E. Cortes, MD, of Georgia Cancer Center at Augusta University, discusses new findings on vodobatinib, which was administered to patients with chronic-phase Philadelphia chromosome–positive chronic myeloid leukemia (CML) and appeared to be efficacious and safe in people who had received therapy with two or three prior tyrosine kinase…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
A summary of our recent presentation at #ASH2022 on Vodobatinib for patients who have received multiple prior TKIs. https://t.co/pHHdHMGxfn
-
-
Mashup Score: 0High-Dose Chemo, ASCT Improves Survival in Primary CNS Lymphoma - 1 year(s) ago
European trial is ‘practice-changing as of today,’ says U.S. expert
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What we heard this week @medpagetoday 🧵⬇ "That's a big deal, that's life and death. That is the gold standard of all cancer research." -- @joshuabrodyMD, of @TischCancer. https://t.co/JwEBUu3BEQ #ASH22 #ASH2022
-
TONIGHT: Join Ajai Chari, MD and other #hematology experts for live updates and data from the ASH Annual Meeting! Sign up now and tune in at 6PM ET: https://t.co/SJq0BKJ3m0 #gotoPER #ASH2022 https://t.co/e5LQcnmBcj